Advertisement

Topics

Neuron Therapeutics Company Profile

17:13 EST 23rd November 2017 | BioPortfolio

Neuron Therapeutics, Inc. ("NTI") is a clinical-stage company developing unique therapies for the treatment of central nervous system (CNS) disorders through the application of proprietary pharmaceutical and drug delivery technologies. NTI is bringing these technologies to bear on the treatment of subarachnoid hemorrhage, stroke, spinal cord injury and traumatic brain injury. These conditions represent large, unmet needs within the growing field of neuromedicine.

Location

81 Great Valley Parkway, Great Valley Corporate Center
Makvern
PA
19355
United States of America

Contact

Phone: (610) 578-9494
Fax: 610) 578-9205


News Articles [635 Associated News Articles listed on BioPortfolio]

MIT engineers devise automated approach to monitor neurons

Recording electrical signals from inside a neuron in the living brain can reveal a great deal of information about that neuron's function and how it coordinates with other cells in the brain.

Mapping the brain, neuron by neuron

(Johns Hopkins University) A mathematician and computer scientist joined an international team of neuroscientists to create a complete map of the learning and memory center of the fruit fly larva brai...

Robotic system monitors specific neurons

Recording electrical signals from inside a neuron in the living brain can reveal a great deal of information about that neuron's function and how it coordinates with other cells in the brain. However,...

Neuron types in brain are defined by gene activity shaping their communication patterns

(Cold Spring Harbor Laboratory) In a major step forward, scientists at CSHLtoday publish a discovery about the molecular-genetic basis of neuronal cell types. Neurons are the basic building blocks th...

Memantine linked to lower neuron-specific enolase in TBI

(HealthDay)—For patients with moderate traumatic brain injury (TBI), memantine is associated with reduced neuronal damage, as assessed by serum levels of neuron-specific enolase (NSE), according to ...

New pathogenic mechanism of motor neuron disorders

Scientists have found a previously unknown pathogenic mechanism of motor neuron disorders. The discovery may lead to a rethinking in drug development.

Survival Motor Neuron Protein Component Of Gems 1 or Gemin 1 or SMN1 or SMN2 Pipeline Review, H2 2017 [Report Updated: 18072017] Prices from USD $3500

Survival Motor Neuron Protein Component Of Gems 1 or Gemin 1 or SMN1 or SMN2 Pipeline Review, H2 2017SummaryAccording to the recently published report 'Survival Motor Neuron Protein Pipeline Review,...

How do adult brain circuits regulate new neuron production?

(University of North Carolina Health Care) UNC school of Medicine researchers identified a brain circuit that controls neuron development in the adult brain. It runs from near the front of the brain b...

PubMed Articles [742 Associated PubMed Articles listed on BioPortfolio]

Netrin-Mediated Axon Guidance to the CNS Midline Revisited.

Varadarajan et al. (2017)-in this issue of Neuron-and Dominici et al. (2017)-published online at Nature-independently show that floor plate-derived netrin-1 is dispensable for commissural neuron axo...

Antibiotic drug piperacillin induces neuron cell death through mitochondrial dysfunction and oxidative damage.

Although nerve damage/toxicity has been shown to be one of the side effects in patients given prolonged antibiotic treatment, the mechanisms of the action of antibiotics on neuron cells are not clear....

Correction: Sensory Neuron-Derived Eph Regulates Glomerular Arbors and Modulatory Function of a Central Serotonergic Neuron.

[This corrects the article DOI: 10.1371/journal.pgen.1003452.].

To Fight or Not to Fight.

In this issue of Neuron, Watanabe et al. (2017) uncover how octopamine, an invertebrate norepinephrine analog, modulates the neural pathways that bias Drosophila males toward aggression.

…with Love, from Post to Pre.

In this issue of Neuron, Costa et al. (2017) introduce a theoretical framework that predicts the ratio of presynaptic and postsynaptic changes taking place during LTP and LTD and show that these proc...

Clinical Trials [191 Associated Clinical Trials listed on BioPortfolio]

Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease

Levetiracetam (Keppra) is used to treat partial onset seizures. Its biological effects suggest it might also be useful in treating 3 aspects of human motor neuron diseases (MNDs) for whic...

Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases

The goal of this study is to establish a genetic registry of patients with early-onset motor neuron and neuromuscular diseases. The investigators will collect samples from patients with a ...

A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.

The COMMEND Study will assess the safety and effectiveness of FLX-787 in men and women with Motor Neuron Disease [including Amyotrophic Lateral Sclerosis (ALS), Primary Lateral Sclerosis (...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Companies [1176 Associated Companies listed on BioPortfolio]

Neuron Therapeutics

Neuron Therapeutics, Inc. ("NTI") is a clinical-stage company developing unique therapies for the treatment of central nervous system (CNS) disorders through the application of proprietary pharmaceuti...

Biokeystone Company

In 1994 a company, Biokey American Instruments, was created in Portland, Oregon near the campus of Oregon Health & Science University. Late in 2006 after relocation to California, a company name...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "Neuron Therapeutics" on BioPortfolio

We have published hundreds of Neuron Therapeutics news stories on BioPortfolio along with dozens of Neuron Therapeutics Clinical Trials and PubMed Articles about Neuron Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Neuron Therapeutics Companies in our database. You can also find out about relevant Neuron Therapeutics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Stroke - Cerebrovascular Disease (CVA)
A stroke is a serious medical condition that occurs when the blood supply to part of the brain is cut off. Strokes are a medical emergency and prompt treatment is essential because the sooner a person receives treatment for a stroke, the less damage is ...


Corporate Database Quicklinks



Searches Linking to this Company Record